MC
DPLO

Menta Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Menta Capital’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,377
Closed -$143K – 1054
2016
Q4 		$143K Sell
11,377
-57,120
-83% -$1.06M 0.01% 820
2016
Q3 		$1.92M Buy
+68,497
New +$2.3M 0.18% 181
2016
Q2 		– Sell
-7,300
Closed -$200K – 1032
2016
Q1 		$200K Buy
+7,300
New +$215K 0.03% 818

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Menta Capital's DPLO Position: Q1 2017 in Review

Menta Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2017, closing a stake of 11,377 shares — an estimated $143K sold.

Menta Capital first reported a position in DPLO in Q1 2016 and held it in 3 quarters. The position peaked at $1.92M in Q3 2016. 155 funds tracked by Wall St. Rank hold DPLO as of Q1 2017.

  • Menta Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2017 after selling out during the quarter.
  • Menta Capital sold 11,377 DIPLOMAT PHARMACY, INC. shares in Q1 2017, an estimated $143K.
  • Menta Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 3 quarters.
  • Menta Capital's DIPLOMAT PHARMACY, INC. position peaked at $1.92M in Q3 2016.
  • 155 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2017.

Based on Menta Capital's 13F filing for Q1 2017, filed 12 May 2017.